Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-21-052391

President & CEO sold 11,515 shares at $13.83 ($159,252)

From the SEC's structured data for this filing

Trades in this filing

ROBIN HOWARD W · President & CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-08-16 Sale : show line 1 in the form −11,515 $13.83 $159,252 424,123 D
Open-market sales · 11,515 sh · avg $13.83 · $159,252
Loading xslF345X03/doc4.xml…